Study detects 'chemobrain' in EEG activity

June 4, 2012

A Cleveland Clinic study has detected significant changes in the electroencephalogram (EEG) brain activity patterns of patients receiving chemotherapy.

The study may give scientific evidence of a condition commonly referred to as "chemobrain" – the fogginess that many patients experience while on chemotherapy. Patients with chemobrain often report short-term memory problems and difficulty concentrating.

"The EEG study demonstrated a higher amplitude, or more brain activity in women, during that particularly went up after doing a cognitive task and also after doing a physical task," said Halle Moore, M.D., a staff physician in Cleveland Clinic's solid tumor oncology unit.

The year-long study involved eight pairs of patients undergoing treatment for breast cancer.

Explore further: Asian breast cancer survivors suffer cognitive impairments associated with chemotherapy

Related Stories

Mayo Clinic launches whole genome breast cancer study

April 9, 2012

The Breast Cancer Genome Guided Therapy Study (BEAUTY Project) will help physicians tailor chemotherapy to breast cancer patients based on their individual genomes and the genomes of their tumors. Mayo Clinic researchers ...

Recommended for you

Study sheds light on how ovarian cancer spreads

June 27, 2017

With 20,000 diagnoses each year, ovarian cancer is the ninth most common cancer and fifth leading cause of cancer death among women in the United States. So many women die from ovarian cancer because it often goes undetected ...

Cancer hijacks natural cell process to survive

June 26, 2017

Cancer tumours manipulate a natural cell process to promote their survival suggesting that controlling this mechanism could stop progress of the disease, according to new research led by the University of Oxford.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.